Importance of early detection of phenylketonuria in neonates

Authors

DOI:

https://doi.org/10.35381/s.v.v8i1.3846

Keywords:

Phenylketonurias, phenylketonuria maternal, prolidase deficiency, (Source: DeCS)

Abstract

Objective: To analyze the importance of early detection of phenylketonuria in neonates. Method: Descriptive documentary. Conclusion: Phenylketonuria is a pathology caused by a metabolic error due to the lack of functionality of phenylalanine hydroxylase, since the body does not properly synthesize this essential amino acid to form tyrosine. Not having an adequate control causes high levels of phenylalanine in the body triggering damage to the central nervous system resulting in brain pathologies, this disease is also determined as congenital because it can be inherited being the parents their carriers.

Downloads

Download data is not yet available.

References

Rovelli V, Longo N. Phenylketonuria and the brain. Mol Genet Metab. 2023;139(1):107583. https://doi.org/10.1016/j.ymgme.2023.107583

Phenylketonuria (PKU). In: Mother To Baby | Fact Sheets. Brentwood (TN): Organization of Teratology Information Specialists (OTIS); November 2022.

Wiedemann A, Oussalah A, Jeannesson É, Guéant JL, Feillet F. La phénylcétonurie - De la diététique à la thérapie génique [Phenylketonuria, from diet to gene therapy]. Med Sci (Paris). 2020;36(8-9):725-734. https://doi.org/10.1051/medsci/2020127

Elhawary NA, AlJahdali IA, Abumansour IS, et al. Genetic etiology and clinical challenges of phenylketonuria. Hum Genomics. 2022;16(1):22. https://doi.org/10.1186/s40246-022-00398-9

van Spronsen FJ, Blau N, Harding C, Burlina A, Longo N, Bosch AM. Phenylketonuria. Nat Rev Dis Primers. 2021;7(1):36. https://doi.org/10.1038/s41572-021-00267-0

Levy HL. Robert Guthrie and the Trials and Tribulations of Newborn Screening. Int J Neonatal Screen. 2021;7(1):5. https://doi.org/10.3390/ijns7010005

Appelberg K, Sörensen L, Zetterström RH, Henriksson M, Wedell A, Levin LÅ. Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism. J Pediatr. 2023;256:38-43.e3. https://doi.org/10.1016/j.jpeds.2022.10.046

Ajami N, Soleimani A, Jafarzadeh-Esfehani R, Hasanpour M, Rashid Shomali R, Abbaszadegan MR. Mutational landscape of phenylketonuria in Iran. J Cell Mol Med. 2023;27(17):2457-2466. https://doi.org/10.1111/jcmm.17865

Phenylketonuria. Nat Rev Dis Primers. 2021;7(1):35. https://doi.org/10.1038/s41572-021-00274-1

Vardy ERLC, MacDonald A, Ford S, Hofman DL. Phenylketonuria, co-morbidity, and ageing: A review. J Inherit Metab Dis. 2020;43(2):167-178. https://doi.org/10.1002/jimd.12186

Lachmann R, Langeveld M. Phenylketonuria in adults: what do we know?. Am J Clin Nutr. 2024;119(4):870-871. https://doi.org/10.1016/j.ajcnut.2024.01.023

Firman SJ, Ramachandran R, Whelan K, Witard OC, O'Keeffe M. Protein status in phenylketonuria: A scoping review. Clin Nutr. 2022;41(4):894-922. https://doi.org/10.1016/j.clnu.2022.02.010

Couce ML. Sleep disorders in phenylketonuria. Eur J Paediatr Neurol. 2019;23(5):670-671. https://doi.org/10.1016/j.ejpn.2019.09.002

Manta-Vogli PD, Dotsikas Y, Loukas YL, Schulpis KH. The phenylketonuria patient: A recent dietetic therapeutic approach. Nutr Neurosci. 2020;23(8):628-639. https://doi.org/10.1080/1028415X.2018.1538196

Dobrowolski SF, Phua YL, Vockley J, Goetzman E, Blair HC. Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity. Mol Genet Metab. 2022;136(2):111-117. https://doi.org/10.1016/j.ymgme.2022.03.012

Published

2024-02-01

How to Cite

Freire-Martínez, E. B., Freire-Tenecota, A. B., Gutiérrez-Navas, T. de J., & Alfonso-González, I. (2024). Importance of early detection of phenylketonuria in neonates. Revista Arbitrada Interdisciplinaria De Ciencias De La Salud. Salud Y Vida, 8(1), 905–913. https://doi.org/10.35381/s.v.v8i1.3846

Issue

Section

Original breve

Most read articles by the same author(s)

1 2 3 > >>